Key result
Holter-detected NSVT is linked to ~60% higher mortality in males but not females.
Why the study?
Nonsustained ventricular tachycardia is common and linked to increased mortality, but sex differences in its prognostic significance in real-life outpatients are unclear.
Does the presence of NSVT on Holter monitoring predict mortality differently in male versus female outpatients?
Cohort (n=1,455)
No
Does the presence of NSVT on Holter monitoring predict mortality differently in male versus female outpatients?
NSVT detected on symptom-driven Holter monitoring is associated with increased all-cause mortality in men but not in women, suggesting sex-specific risk stratification may be necessary.
Background: Nonsustained ventricular tachycardia (NSVT) is a common finding during cardiac evaluation and has been linked to increased mortality. While some studies report a sex difference, most data stem from research cohorts. Objective: This study aimed to assess the prognostic significance of NSVT in a real-life outpatient clinic, focusing on sex differences in mortality. Methods: Analysis was performed on a cohort of consecutive patients referred to 48-hour Holter monitoring between 2009 and 2011 at Copenhagen University Hospital - Bispebjerg. Indications for Holter monitoring included palpitations, dizziness, syncope, or arrhythmia testing. Baseline characteristics, blood tests, echocardiography results, and mortality data were obtained from electronic patient records. Results: A total of 762 females (mean age 59 ± 18 years) and 693 males (mean age 59 ± 17 years) were enrolled. At least 1 episode of NSVT was detected in 9.7% of females and 20.6% of males. The median follow-up was 8.3 years. A total of 20% of females and 24% of males died during follow-up. In multivariable models, NSVT was linked to mortality in males (hazard ratio [HR] 1.6, 95% confidence interval [CI] 1.1-2.3) but not in females (HR 1.2, 95% CI 0.7-2.1). In case-control pairs matched on the propensity of being male conditional on relevant risk factors, NSVT was again linked to mortality in males (HR 3.1, 95% CI 2.0-4.8) but not in females (HR 1.4, 95% CI 0.8-2.4). Conclusion: In consecutive patients referred to symptom driven Holter monitoring, NSVT was associated with elevated all-cause mortality in males but not in females. These results can contribute to the risk assessment of patients presenting with NSVT.
No takes yet. Share an insight, caveat, or question.
Christiansen et al. (2024) conducted a cohort in Patients referred for Holter monitoring (n=1,455). Nonsustained ventricular tachycardia (NSVT) vs. Absence of NSVT was evaluated on Mortality (HR 1.6, 95% CI 1.1-2.3). Nonsustained ventricular tachycardia detected on Holter monitoring was associated with increased mortality in males (HR 1.6; 95% CI 1.1-2.3) but not in females (HR 1.2; 95% CI 0.7-2.1).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: